AstraZeneca | AstraZeneca | employment discrimination | 2021 | OFCCP | $560,000 |
AstraZeneca | AstraZeneca | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $198,000,000 |
AstraZeneca | AstraZeneca | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
ALEXION PHARMACEUTICALS, INC. | AstraZeneca | workplace safety or health violation | 2012 | OSHA | $8,213 |
MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | environmental violation | 2005 | EPA | $21,125 |
ASTRAZENECA PLP | AstraZeneca | environmental violation | 2021 | EPA | $18,960 |
ISTA Pharmaceuticals, Inc. | Bausch Health | False Claims Act and related | 2013 | DOJ_CIVIL | $33,500,000 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $9,800,000 |
ICN Pharmaceuticals, Inc | Bausch Health | economic sanction violation | 2004 | OFAC | $5,500 |
Biovail Corporation | Bausch Health | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | benefit plan administrator violation | 2016 | EBSA | $10,001 |
BIOVAIL AMERICAS CORP. | Bausch Health | benefit plan administrator violation | 2012 | EBSA | $10,001 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | USAO | $54,000,000 |
Biovail Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2009 | USAO | $24,647,876 |
ICN Pharmaceuticals, Inc. | Bausch Health | fraud | 2001 | USAO | $5,600,000 |
Medicis Pharmaceutical | Bausch Health | employment discrimination | 2016 | private lawsuit-federal | $7,150,000 |
Bausch & Lomb | Bausch Health | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
Biovail | Bausch Health | False Claims Act and related | 2013 | LA-AG | $200,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $390,253 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | investor protection violation | 2017 | MULTI-AG | $145,000,000 |
Valeant Pharmaceuticals, Inc. | Bausch Health | insurance violation | 2018 | CA-INS | $1,875,000 |
Bausch Health | Bausch Health | accounting fraud or deficiencies | 2020 | SEC | $45,000,000 |
Bausch & Lomb Inc. | Bausch Health | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
Bausch Health Companies Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $300,000,000 |
Medicis Pharmaceutical Corp. | Bausch Health | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $23,000,000 |
Medicis Pharmaceutical Corp. | Bausch Health | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $35,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $37,500,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
BAUSCH AND LOMB PHARMACEUTICALS, INC. | Bausch Health | workplace safety or health violation | 2000 | OSHA | $7,000 |
Biocryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | environmental violation | 2014 | AL-ENV | $11,000 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
Biogen Idec Inc. | Biogen | wage and hour violation | 2005 | WHD | $6,934 |
Biogen Idec Inc. | Biogen | consumer protection violation | 2007 | VT-AG | $10,000 |
Biogen, Inc. | Biogen | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
Biogen Inc. | Biogen | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
BIOGEN IDEC, INC. | Biogen | workplace safety or health violation | 2014 | OSHA | $7,500 |
Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
Boehringer Ingelheim Pharmaceutical, Inc. | Boehringer Ingelheim | labor relations violation | 2004 | NLRB | $50,000 |
BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | aviation safety violation | 2014 | FAA | $15,000 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | employment discrimination | 2020 | OFCCP | $379,089 |
Boehringer Ingelheim International | Boehringer Ingelheim | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | environmental violation | 2008 | EPA | $3,650,000 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | economic sanction violation | 2004 | OFAC | $6,600 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | wage and hour violation | 2004 | WHD | $160,203 |
Bristol-Myers Squibb Medical Imaging, Inc. | Bristol-Myers Squibb | export control violation | 2004 | BIS | $16,200 |
Celgene Corp. | Bristol-Myers Squibb | False Claims Act and related | 2017 | USAO | $280,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
Briston-Myers Squibb | Bristol-Myers Squibb | benefit plan administrator violation | 2005 | private lawsuit-federal | $41,220,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $100,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Celgene Corp. | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | environmental violation | 2011 | CT-ENV | $20,000 |
E R SQUIBB & SONS LLC | Bristol-Myers Squibb | environmental violation | 2013 | NJ-ENV | $5,950 |
E.R. SQUIBB & SONS | Bristol-Myers Squibb | environmental violation | 2009 | NJ-ENV | $10,000 |
BRISTOL MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2005 | NJ-ENV | $12,000 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2003 | NJ-ENV | $28,000 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2001 | NJ-ENV | $6,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2021 | USAO | $75,000,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
Abraxis Bioscience, Inc. | Bristol-Myers Squibb | environmental violation | 2012 | CA-SCAQMD | $5,000 |
American BioScience Inc. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $65,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $220,000,000 |
Celgene Corporation | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $34,000,000 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $44,500,000 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | environmental violation | 2023 | MA-ENV | $11,615 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | environmental violation | 2009 | EPA | $19,538 |